Positron-emission tomographic CT (PET-CT) is gaining greater acceptance in a wide variety
of oncologic indications in numerous organ systems (head and neck, central nervous …

Head and neck squamous cell carcinoma (HNC) is the sixth most common cancer
worldwide. In the United States, it accounts for approximately 2% of all cancers and 2% of …

Positron emission tomographic–computed tomographic (PET-CT) imaging of patients with
primary head and neck cancers has become an established approach for staging and …

The hybrid technique of PET/CT has significantly impacted the imaging and management of
HNSCC since its introduction in 2001 and has become the technique of choice for imaging …

Abstract Objectives/Hypothesis: Positron emission tomography (PET) has shown promise for
early detection and accurate staging of cancer patients. A limited number of studies suggest …

Background: Positron emission tomography/computed tomography (PET/CT) is a newer
imaging modality that combines whole-body PET using [18F] fluorodeoxyglucose (FDG) and …

Objectives/Hypothesis Combined positron emission tomography with simultaneous
computed tomography (PET/CT performed using 18F‐fluorodeoxyglucose [FDG] as a …

Purpose: To determine the value of PET scans in the staging of patients with head and neck
carcinoma. Methods and Materials: The charts of 25 patients who underwent neck …

Simple Summary Positron emission tomography (PET), typically combined with computed
tomography (CT) has become a critical advanced imaging technique in oncology. With PET …

The purpose of this article is to elucidate the role of 2-[18F] Fluoro-2-deoxy-D-glucose (FDG)
positron emission tomography (PET) in evaluating patients with head and neck cancer. This …